Review Papers Claim by Claim

Concise critical takeaways

• This April 2025 Journal of Fungi review synthesizes evidence that Fusarium is a transkingdom pathogen with high intrinsic and emerging acquired resistance to azoles and amphotericin B and with clinically relevant biofilm formation in keratitis and onychomycosis Fusarium
• Key mechanistic emphasis: Fusarium carries three CYP51 paralogs (A B C), shows inducible CYP51A overexpression under VOR pressure, promoter variation including a reported 23 bp DEL, Hog1 MAPK FgSR regulatory axis, and candidate efflux activity — but functional clinical validation is limited CYP51
• Biofilm analysis: ECM lipid rich early biofilms shift to polysaccharide protein dominant mature biofilms; VOR showed greater anti-biofilm efficacy than AmB in cited assays, but authors note biofilms alone do not fully explain azole resistance mechanisms Biofilm

Full evidence based review and critique

The paper The Dual Pathogen Fusarium Diseases Incidence Azole Resistance and Biofilms published April 09 2025 in Journal of Fungi is a comprehensive review assembling clinical epidemiology diagnostics molecular mechanisms of azole resistance and biofilm biology for Fusarium spp The review is useful and timely but has identifiable gaps that limit causal inference about environmental drivers and functional validation of molecular markers Below I summarize strengths weaknesses evidence and prioritized next experiments with explicit inline source citations for every factual claim

1 Key claims of the paper with supporting excerpts and appraisal

1. Fusarium is a clinically important dual pathogen with major superficial disease burden The authors compile incidence and disease spectrum noting global fungal keratitis burden ~1 000 000 up to 1 400 000 cases annually with Fusarium accounting for roughly 45 53 percent of culture positive keratitis in many tropical regions and frequent involvement in onychomycosis chronicity and treatment failure Disease Appraisal The epidemiology synthesis is thorough for keratitis and nails but the review correctly flags limited national level surveillance for invasive fusariosis so incidence estimates for IF remain hospital based and heterogeneous which reduces generalizability
2. High antifungal resistance including to azoles and amphotericin B The review compiles multiple in vitro susceptibility reports and reports the authors own dataset of 29 clinical isolates with 85 percent resistance to voriconazole and ongoing screening of >100 nail isolates with preliminary cross azole and MDR findings Reported Appraisal The reported 85 percent figure is alarming but is from small unpublished datasets described in the review Authors transparently label some datasets as manuscript in preparation which raises the need for peer reviewed phenotypic data and standardized susceptibility methods and quality controlled MIC determinations
3. Molecular mechanisms likely differ from Aspergillus Fusarium harbors three CYP51 paralogs CYP51A CYP51B CYP51C and shows distinct regulation with CYP51A inducible to VOR exposure CYP51B often constitutive expression and possible redundancy The authors highlight promoter variants including a 23 bp CYP51A promoter deletion in some FSSC isolates and implicate Hog1 MAPK FgSR axis in ergosterol regulation CYP51 Appraisal The mechanistic narrative is coherent and consistent with fungal physiology literature However direct functional validation linking specific paralog SNPs promoter alterations or Hog1/FgSR changes to clinical MICs in human isolates is sparse in the literature so causality remains provisional
4. Biofilms contribute to persistence but do not fully explain azole resistance The review documents in vitro ex vivo and in vivo biofilm models for keratitis and onychomycosis ECM composition dynamics lipid rich early biofilm shifting to polysaccharide protein dominated mature biofilm lipids in nail ECM peak at day 7 and voriconazole showed greater anti biofilm efficacy than amphotericin B in several assays Biofilm Appraisal The experimental biofilm descriptions are valuable for translational approaches But the paper rightly emphasizes that biofilm state cannot by itself account for the severe azole resistance observed across diverse clinical isolates and species complexes

2 Strengths

• Comprehensive: integrates clinical epidemiology diagnostics molecular genetics biofilm biology and agricultural perspectives with 100 references Comprehensive
• Highlights underappreciated complexities such as multiple CYP51 paralogs promoter regulation Hog1 FgSR signaling and metabolic drivers of biofilm ECM composition all of which are important paths for functional studies Mechanistic

3 Weaknesses and limitations

1. Heavy reliance on small unpublished datasets The alarming 85 percent VOR resistance figure is from the authors small 29 isolate set and other large claims refer to manuscripts in preparation This is acceptable for a review but it reduces confidence until the raw data and methods are peer reviewed Unpublished
2. Insufficient population scale ecological linkage While agricultural azole use is plausibly implicated the paper acknowledges absence of genetic signatures analogous to Aspergillus TR34 L98H that would prove environmental origin of resistance for Fusarium Thus the One Health link remains plausible but unproven Environmental
3. Functional gaps for CYP51 SNPs The review reports many SNP correspondences between Aspergillus resistant sites and Fusarium paralogs but lacks direct functional assays demonstrating altered azole binding or in vivo impact for most reported Fusarium variants The paper flags this gap correctly CYP51
4. Heterogeneous susceptibility testing The review cites many in vitro MIC results from diverse labs without a unified susceptibility standard which complicates cross study comparisons The authors note the problem and call for larger standardized datasets

4 Practical implications and what should change

• Clinical surveillance Standardized susceptibility testing across species complexes is essential publish raw MIC data and sequence data for clinical isolates publicly to enable meta analyses
• Functional validation Generate isogenic mutants of CYP51 paralogs and promoter variants and measure MICs biofilm phenotypes ergosterol content and fitness trade offs in infection models
• Environmental One Health studies Pair culture and WGS of isolates from agriculture hospital water and patient infections in matched geographies to test transmission hypotheses and look for shared resistance genotypes
• Biofilm therapeutics Prioritize early biofilm lipid targeting agents and combination regimens in ex vivo nail and corneal models using clinically relevant developmental phase susceptibility testing rather than conidial assays alone

5 Recommended targeted experiments

1. CRISPR Cas9 mediated deletion and allele swap experiments in a clinical F solani background to test candidate CYP51A SNPs and the 23 bp promoter DEL measuring MICs to VOR POS ISA AmB and cell fitness in vitro and in vivo
2. Paired environmental clinical surveillance WGS study in a high azole agricultural region sampling soil wastewater hospital water and patient isolates sequence CYP51 paralogs and compare population structure
3. Time course biofilm lipidomics ergosterol quantification and drug penetration assays at early middle late biofilm stages to test whether early lipid targeting improves antifungal kill in ex vivo nail and corneal models

6 Visualization of key extracted data

7 Final balanced evaluation

The review is a high value synthesis for clinicians mycologists and plant pathologists summarizing disease burden resistance mechanisms and biofilm biology and setting a helpful research agenda It scores well for novelty and explanatory depth relative to prior Fusarium reviews but its most attention grabbing claims currently rest partly on small unpublished datasets and correlative ecological reasoning that require prospective functional and epidemiological validation All claims above are drawn explicitly from the review and are cited verbatim where possible Review

Author Review Links